miPT
Selected indexed studies
- Recent advances in therapeutic strategies for triple-negative breast cancer. (J Hematol Oncol, 2022) [PMID:36038913]
- Pathophysiological impacts of 5-MeO-MiPT on zebrafish (Danio rerio) via the Gα(q/11)-PLC(β) signaling pathway. (Ecotoxicol Environ Saf, 2024) [PMID:39216220]
- New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study. (Balkan Med J, 2021) [PMID:32936075]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Recent advances in therapeutic strategies for triple-negative breast cancer. (2022) pubmed
- Pathophysiological impacts of 5-MeO-MiPT on zebrafish (Danio rerio) via the Gα(q/11)-PLC(β) signaling pathway. (2024) pubmed
- New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study. (2021) pubmed
- Muscle strength in breast cancer patients receiving different treatment regimes. (2017) pubmed
- Nontargeted metabolomic insights into the behavioral effects of 5-MeO-MiPT in zebrafish (Danio rerio). (2024) pubmed
- Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence. (2024) pubmed
- Biotransformation of 5-methoxy-N-isopropyl-N-methyltryptamine by zebrafish and human liver microsome with high-resolution mass spectrometry. (2024) pubmed
- Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples. (2018) pubmed
- The impact of music-imaginative pain treatment (MIPT) on psychophysical affect regulation - A single case study. (2022) pubmed
- Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. (2021) pubmed